CD19/CD5 acute lymphoblastic leukemia
✍ Scribed by Subirá, Dolores; Roman, Alejandro; Jiménez-Garófano, Carmen; Prieto, Elena; Martínez-Delgado, Beatriz; Aceituno, Esther; García, Rosa; Outeiriño, Julio
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 260 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0098-1532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A 22-year-old woman presented with acute lymphoblastic leukemia (ALL) during pregnancy. She had been successfully treated for ALL at the age of 3 years and had received maintenance treatment for 11 years. Complete remission of 3 years or more is an important factor for long-term survival and potenti
Aberrant CD2 expression in childhood precursor-B ALL is rare and has recently been reported with an incidence of 3.6% in a study by Cantu-Rajnoldi et al. [Haematologica 77:384, 19921. There was no association of the CD2 co-expression with other known prognostic factors. Our study represents the seco